PDS Biotechnology Corp (PDSB): Short seller scumbags

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	98
Boards Moderated	0
Alias Born	01/02/2014

quicksniff

Re: Ruffieruff post# 1084

Tuesday, 04/27/2021 4:30:18 PM

Tuesday, April 27, 2021 4:30:18 PM

Short seller scumbags

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PDSB News

Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 12:05:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:05:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:05:43 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/13/2024 08:39:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:13:03 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:06:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:00:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:00:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:00:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 12:00:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:45:39 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 12:05:41 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:16:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:00:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:05:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:33:38 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:31:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 10:10:16 PM
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 01/22/2024 09:45:19 PM
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/04/2023 09:50:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:02:38 PM
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer • GlobeNewswire Inc. • 11/28/2023 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 11:02:46 AM
PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 12:30:55 PM

More PDSB News

InvestorsHub NewsWire

North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover